Browsing Tag
Patient-reported outcomes
1 post
Abivax delivers breakthrough Phase 3 data: obefazimod improves quality of life in moderate-to-severe ulcerative colitis
Discover how Abivax’s obefazimod improved quality of life and achieved remission in Phase 3 ulcerative colitis trials—see why experts call it a game changer.